Deerfield-based Baxter International announced Monday that its CEO and board Chair José Almeida is retiring, effective immediately — an announcement that came just days after the company sold ...

Baxter raised the lower end of its 2025 profit forecast range to $2.47 to $2.55 per share, compared with a prior view of $2.45 to $2.55. Reporting by Kamal Choudhury and Christy Santhosh in ...

On August 13, 2024, Baxter International Inc. (NYSE: BAX, $36.12, Market Capitalization: $18.4 billion), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ: CG ...

Baxter is a top-tier medical supplier and capital equipment maker. Its financial results fell substantially in 2022-23 on external pressures like inflation and weak medical utilization trends.